Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - fentanyl (unii: uf599785jz) (fentanyl - unii:uf599785jz) - fentanyl 25 ug in 1 h - fentanyl transdermal system is indicated for the management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. patients considered opioid-tolerant are those who are taking, for one week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily, or an equianalgesic dose of another opioid. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve fentanyl transdermal system for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. fentanyl transdermal system is contraindicated in the following

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets, usp are indicated for the relief of mild to moderately severe pain. codeine-containing products are contraindicated for post-operative pain management in children who have undergone tonsillectomy and/or adenoidectomy. acetaminophen and codeine phosphate tablets should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. controlled substance acetaminophen and codeine phosphate tablets are classified as a schedule iii controlled substance. drug abuse and dependence codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence and tolerance may develop upon repeated administration, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets, usp are indicated for the relief of mild to moderately severe pain. codeine-containing products are contraindicated for post-operative pain management in children who have undergone tonsillectomy and/or adenoidectomy. acetaminophen and codeine phosphate tablets should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. acetaminophen and codeine phosphate tablets are classified as a schedule iii controlled substance. codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence and tolerance may develop upon repeated administration, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

proficient rx lp - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets, usp are indicated for the relief of mild to moderately severe pain. codeine-containing products are contraindicated for post-operative pain management in children who have undergone tonsillectomy and/or adenoidectomy. acetaminophen and codeine phosphate tablets should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. click here to enter use in specific populations click here to enter pregnancy click here to enter lactation click here to enter females and males of reproductive potential click here to enter pediatric use click here to enter geriatric use controlled substance acetaminophen and codeine phosphate tablets are classified as a schedule iii controlled substance. drug abuse and dependence codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence and tolerance may develop upon repeated administration, and i

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

rxchange co. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets, usp are indicated for the relief of mild to moderately severe pain. codeine-containing products are contraindicated for post-operative pain management in children who have undergone tonsillectomy and/or adenoidectomy. acetaminophen and codeine phosphate tablets should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. controlled substance acetaminophen and codeine phosphate tablets are classified as a schedule iii controlled substance. drug abuse and dependence codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence and tolerance may develop upon repeated administration, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

triax pharmaceuticals, llc - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) - tretinoin 0.25 mg in 1 g - tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. the safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established. use of the product should be discontinued if hypersensitivity to any of the ingredients is noted. safety and effectiveness in pediatric patients below the age of 12 have not been established. safety and effectiveness in a geriatric population have not been established. clinical studies of tretinoin did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients.

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - cabergoline - oral tablet - 500microgram

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

clinigen healthcare ltd - interferon gamma-1b (recombinant human) - solution for injection - 200microgram/1ml

Irska - engleski - HPRA (Health Products Regulatory Authority)

laboratorios leon farma, s.a. - dienogest; ethinylestradiol - film-coated tablet - 2.0 mg/0.03 milligram(s) - progestogens and estrogens, fixed combinations; dienogest and estrogen

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - tacrolimus monohydrate - cutaneous ointment - 1mg/1gram